CARRIAGE OF MULTIDRUG RESISTANT ENTEROCOCCUS FAECIUM AND ENTEROCOCCUS FAECALIS AMONG APPARENTLY HEALTHY HUMANS by Adesida, Solayide A. et al.
Adesida et al., Afr., J. Infect. Dis. (2017) 11 (2): 83-89 
https://doi.org/10.21010/ajid.v11i2.11 
 
83 
 
CARRIAGE OF MULTIDRUG RESISTANT ENTEROCOCCUS FAECIUM AND ENTEROCOCCUS 
FAECALIS AMONG APPARENTLY HEALTHY HUMANS 
 
Solayide A. Adesida1*, Cynthia C. Ezenta1, Ajoke O. Adagbada2, Amudat A. Aladesokan3 and Akitoye 
O. Coker4 
1Department of Microbiology, Faculty of Science, University of Lagos, Lagos, Nigeria, 2Molecular Biology 
and Biotechnology Division, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria, 3Department of 
Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Idi-Araba, Lagos, 
Nigeria, 4Department of Medical Microbiology and Parasitology, Babcock University Teaching Hospital, 
Ilishan-Remo, Ogun State, Nigeria. 
 
*Corresponding author E-mail: sadesida@unilag.edu.ng ; sadesidashittu@gmail.com  
 
Abstract 
 
Background:Enterococci are indigenous flora of the gastro-intestinal tracts of animals and humans. Recently, interest 
in two major species, E. faecium and E. faecalis, has heightened because of their ability to cause serious infections and 
their intrinsic resistance to antimicrobials. This study was aimed at determining the prevalence of E. faecium and E. 
faecalis in human faecal samples and evaluating the susceptibility of the isolates to antibiotics. 
Materials and Methods:One hundred faecal samples were collected from apparently healthy individuals and analysed 
using conventional bacteriological methods. The susceptibility profile of the isolates to nine antibiotics were 
determined using disk diffusion method. 
Results: Seventy-three (73) Enterococcus were phenotypically identified and 65 of the isolates were differentiated into 
36 (55.4%) E. faecium and 29 (44.6%) E. faecalis. Eight (8) isolates could not be identified by the conventional 
biochemical methods employed.  No dual colonization by the E. faecalis and E. faecium was observed and isolation 
rate was not dependent on sex of the participants. All the isolates were resistant to ceftriaxone, cefuroxime and 
ceftizoxime. Enterococcus faecium exhibited resistance to erythromycin (88.9%), gentamicin (77.8%), amoxicillin-
clavulanate (63.9%), ofloxacin (44.4%), teicoplanin (19.4%) and vancomycin (16.7%). Enterococcus faecalis showed 
the least resistance to vancomycin (13.8%) and teicoplanin (27.7%). Remarkable multiple antibiotic resistances to the 
classes of antibiotic tested were observed among the two species. 
Conclusion: The high carriage rate of antibiotic resistant E. faecium and E. faecalis in this study provides information 
on the local antibiotic patterns of our enterococci isolates thereby suggesting that they could present as important 
reservoir and vehicle for dissemination of resistant genes in our community. 
 
Keywords: Enterococcus faecium, Human faecal samples, Enterococcus faecalis, Biochemical identification, 
Antibiotic resistance. 
 
Introduction 
 
Members of the genus Enterococcus, are characterized by individual, paired, or short-chain Gram-positive 
catalase-negative cocci (Ciftci et al., 2009). Although, ubiquitous, they are primarily localized to the human gut and are 
found in human faeces, where they represent a minority population (up to 1%) within the gut microflora (Song et al., 
2005; Bibalan et al., 2015). Once considered as bacteria of minimal clinical impact, enterococci, 
particularly Enterococcus faecium and Enterococcus faecalis, have now emerged as one of the major causes of human 
clinical infections (Silva et al., 2011). They have assumed a vital role as etiologic agent of urinary tract infections, 
hospital-acquired bloodstream infections, endocarditis, abdominal and pelvic abscesses and chronic periodontitis 
(Sydnor and Perl, 2011; Qian-Qian et al., 2012). Their importance in such infections is reinforced by their intrinsic and 
acquired resistance to various antimicrobial agents which renders them difficult to treat.  
 Enterococcal colonization is a known risk factor for developing associated infections and is most commonly 
caused by the patients’ own commensal flora (Maschieto et al., 2004). Studies have also confirmed that colonising 
strains of enterococci serve as reservoir for antibiotic resistance genes which can be transferred among enterococci or 
acquired by other bacteria (Schjørring and  Krogfelt, 2011; Boehm and Sassoubre, 2014). High-density colonization by 
antibiotic-resistant enterococci increases the risk of infections like bacteremia (Lebreton et al., 2014; Tedim et al., 
2015).  These infections are difficult to treat; chronic, recurrent and sometimes fatal.  Thus, there is a need to assess 
colonisation of multiple antibiotic-resistant enterococci especially in developing countries where the control of 
antibiotic use is derisory. In Nigeria, most studies on enterococci have been conducted on food, animals and 
environmental samples (Oladipo et al., 2013; Olawale et al., 2014; 2015; Ayeni et al., 2016) and a few have examined 
samples from clinical sources (Iregbu et al., 2002, Olawale et al., 2011; Ekuma et al., 2016). We report here the 
prevalence of multidrug resistant faecal E. faecium and E. faecalis isolates among apparently healthy humans. 
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Materials and Methods 
Ethical issues and Collection of samples 
 
Verbal consent in collection of samples was sought and obtained from each person after explaining the 
procedure. The voiding was done by each participant without any form of coercion. They were provided with wide-
mouthed, leak-proof sterile plastic containers. One hundred (100) faecal samples were collected from the participants 
and their sexes were documented. Other demographic data were not available because most of the participants declined 
to give the required information. The samples were carefully labelled and processed immediately at the Microbiology 
and Parasitology Laboratory, University of Lagos, Idi-Araba. 
 
Isolation and Biochemical Identification  
 
Sterile inoculating loop was used to pick a small portion of the sample which was then streaked on Bile-
esculin agar (Oxoid, UK) plates and incubated at 37oC for 24 hours. Discrete colonies of suspected Enterococcus 
species were sub-cultured for purity on MacConkey and blood agar plates which were also incubated at 37oC for 24 
hours. Species identification was carried out based on Gram stain, cultural characteristics and various biochemical tests 
including catalase reaction, growth in 6.5% NaCl broth, pyruvate utilization test, growth at 45°C and 60°C for 24 hours 
in a nutrient broth, haemolytic reaction on blood agar and carbohydrate (mannitol, lactose, glucose, sorbitol, raffinose, 
fructose, dextrose, xylose, trehalose, galactose, dulcitol, and arabinose) fermentation (Facklam et al., 1999). The 
carbohydrate fermentation tests were performed in agar containing 1% of each sugar.  
 
Antibiotics susceptibility testing 
 
Testing of susceptibility to ceftizoxime (30µg), cefuroxime (30µg), vancomycin (30µg), erythromycin (25µg), 
gentamicin (10µg), teicoplanin (25µg), ceftriaxone (30µg), ofloxacin (5µg) and amoxicillin-clavulanate (30µg) was 
performed by disk diffusion method. The results were interpreted in accordance with the guidelines of the Clinical and 
Laboratory Standards Institute (CLSI, 2009). Isolates were adjudged as multidrug resistant (MDR) if resistance to three 
or more antibiotics of different antimicrobial classes was demonstrated (Magiorakos et al., 2012). Reference strain 
Enterococcus faecalis ATCC 29212 was used as control. 
 
Results 
 
Of the 100 faecal samples analysed, 73 isolates were identified as Enterococcus. The biochemical scheme 
differentiated 65 of the 73 isolates into E. faecalis (29; 44.6%) and E. faecium (36; 55.4%). The phenotypic 
characteristics of eight isolates could not be determined through the conventional methods used and were excluded in 
the overall analyses. All the Enterococcus faecalis isolates fermented sorbitol, mannitol, glucose and lactose but not 
arabinose while E. faecium was able to ferment arabinose, mannitol, glucose and lactose but not sorbitol (Table 1). The 
isolation rate was independent of sex (Table 2) and no individuals exhibited colonisation with dual isolates.  The 
isolated strains of E. faecalis showed resistance to ceftriaxone, cefuroxime and ceftizoxime. The overall antimicrobial 
susceptibility pattern of the isolates is shown in Table 3. A large proportion (96.6%) of the E. faecalis isolates was 
resistant to gentamicin and erythromycin.  Three percent (10.4%) of the isolates were resistant to vancomycin. 
Similarly, E. faecium significantly exhibited high degree of resistance to gentamicin (88.9%) and erythromycin 
(91.7%). Enterococcus faecalis showed the least resistance to vancomycin (13.8%) (Figure 1). Marked multiple 
antibiotic resistances to the classes of antibiotic tested were observed among the two species (Table 4).  
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Table 1: Sugar Utilisation Reaction of Enterococcus faecalis and Enterococcus faecium  
               No of Positive Isolates (%) 
  
E. faecalis 
 
E. faecium 
 
Arabinose 0 (0%) 36 (100%) 
Sorbitol 29 (100%) 0 (0%) 
Mannitol 29 (100%) 36 (100%) 
Glucose 29 (100%) 36 (100%) 
Lactose 29 (100%) 36 (100%) 
Trehalose 29 (100%) 36 (100%) 
Raffinose 29 (100%) 36 (100%) 
Fructose 29 (100%) 36 (100%) 
Dextrose 29 (100%) 36 (100%) 
Xylose 0 (0%) 0 (0%) 
Galactose 29 (100%) 36 (100%) 
Dulcitol 0 (0%) 0 (0%) 
 
 
 
 
Table 2: Gender-wise Distribution of Enterococcus faecium and Enterococcus faecalis 
 
 
 
 
Table 3: Antimicrobial susceptibility of Enterococcus Isolates to antimicrobial agents 
 
Antibiotics E. faecalis E. faecium Total 
S (%) I (%) R (%) S (%) I (%) R (%) S (%) I (%) R (%) 
Vancomycin 25(86.2) 1(3.5) 3(10.4) 30(83.3) - 6(16.7) 55(84.6) 1(1.5) 9(13.8) 
Teicoplanin 18(62.1) - 11(37.9) 29(80.6) - 7(19.4) 47(72.3) - 18(27.7) 
Amoxicillin-
clavulanate 
10(34.5) 1(3.5) 18(62.1) 9(25.0) 4(11.1) 23(63.9) 19(29.2) 5(7.7) 41(63.1) 
Ofloxacin 13(44.8) 3(10.4) 13(44.8) 17(47.2) 3(8.3) 16(44.4) 30(46.2) 6(9.2) 29(44.6) 
Erythromycin 1(3.5) - 28(96.6) 1(2.8) 3(8.3) 32(88.9) 2(3.1) 3(4.6) 60(92.3) 
Gentamicin 1(3.5) - 28(96.6) 8(22.2) - 28(77.8) 9(13.8) - 56(86.2) 
Ceftriaxone - - 29(100) - - 36(100) - - 65(100) 
Cefuroxine - - 29(100) - - 36(100) - - 65(100) 
Ceftizoxime - - 29(100) - - 36(100) - - 65(100) 
 
Abbreviation: S= Susceptible, I= Intermediate, R= Resistant 
 
 
 
Sex No of Samples Collected No of Enterococci 
Isolated 
No of : 
E. faecium E. faecalis 
Male 50 38 16 15 
Female 50 35 20 14 
Total 100 73 36 29 
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Figure 1: Antimicrobial resistance rates of Enterococcus faecalis and Enterococcus faecium isolates from Apparently 
Healthy Humans. Abbreviations: VAN-Vancomycin; TEC-Teicoplanin; AMC - Amoxicillin-clavulanate; OFL- 
Ofloxacin; ERY-Erythromycin; GEN-Gentamicin; CRO - Ceftriaxone; CXM - Cefuroxime; ZOX- Ceftizoxime. 
 
 
Table 4: Resistance Rate of the Isolates to Classes of Antimicrobials Tested 
 
Classes of Antimicrobials Antimicrobial agent Species No. of resistant isolates 
(%) 
 
Glycopeptide 
Vancomycin E. faecium 6 (16.67) 
E. faecalis 3 (10.34) 
Teicoplanin E. faecium 7 (19.44) 
E. faecalis 11 (37.9) 
Beta-lactam inhibitor Amoxicillin-clavulanate E. faecium 23 (63.9) 
E. faecalis 18 (62.1) 
Fluoroquinolone Ofloxacin E. faecium 16 (44.4) 
E. faecalis 13 (44.8) 
Macrolide Erythromycin E. faecium 32 (88.9) 
E. faecalis 28 (96.6) 
Aminoglycoside Gentamicin E. faecium 28 (77.8) 
E. faecalis 28 (96.6) 
 
Cephalosporins 
 
Ceftriaxone 
E. faecium 36 (100) 
E. faecalis 29 (100) 
Cefuroxime E. faecium 36 (100) 
E. faecalis 29 (100) 
Ceftizoxime E. faecium 36 (100) 
E. faecalis 29 (100) 
 
 
Discussion 
 
Enterococcal species are found in high concentrations in alimentary tract of humans and animals and may be 
transferred to other humans through contaminated food animals or the environment (Fisher and Phillips, 2009). 
Enterococcus faecium and E. faecalis have long been known to be significantly important human pathogens that are 
specially responsible for nosocomial infections. In this study, E. faecium was the most dominant species with 
prevalence of 55.4%. This finding is consistent with studies that have established the preponderance of E. faecium in 
healthy human samples with 44.9% E. faecium and 34.7% E. faecalis (Barreto et al. 2009). A similar distribution of 
enterococcal species was observed in poultry (Krocko et al., 2007).  Enterococcus faecium has also been reported as 
the most common species in other studies involving chicken, turkey, pork, and beef (Hayes et al., 2003). However, the 
results presented by authors elsewhere showed a relatively low occurrence of E. faecium compared with E. faecalis 
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among human faecal isolates (Salem-Bekhit et al., 2012). These differences could be attributed to variable host 
dynamism imposed by gender or sex, diet, age or other environmental conditions. We however found no differences in 
the frequency of isolation of either E. faecium or E. faecalis between the samples from male and female, suggesting 
that colonization rate was not sex dependent.  
Most biochemical identification schemes proposed for enterococci are based on the phenotypic patterns of 
clinical isolates. Results from previous studies have suggested wide variability in the biochemical profile of E. faecium 
and E. faecalis isolates from various sources (Facklam and Sahm, 1995, Day et al., 2001). In our case, all the isolates 
exhibited typical metabolic reaction to key phenotypic characteristics investigated. For instance, the E. faecalis isolates 
were able to utilize sorbitol unlike the E. faecium strains, contrary to some reports (Teixeira et al., 1995; Castillo-Rojas 
et al., 2013). Typically, strains of E. faecium would not produce acid from sorbitol but Day et al. (2001) showed that 16 
out of 18 E. faecium isolates utilized sorbitol. On the other hand, Facklam and Sahm (1995) speculated that over 97% 
isolates of E. faecium could not utilize sorbitol. Therefore, combined with other biochemical identification criteria, 
sorbitol fermentation might be a useful marker for the differentiation of E. faecium from E. faecalis isolates in our 
setting. We, nonetheless, need to confirm this with a larger number of isolates in further study.  
In this present communication, very high percentage of resistance to almost all antimicrobial tested were 
demonstrated by the Enterococcus isolates. The multiple antibiotic resistances of our isolates agree with those found in 
other studies (Rams et al., 2013; Komiyama et al., 2016). The recovery of MDR colonising strains of E. faecium and E. 
faecalis highlights the ability to these organisms to develop resistance to an array of antimicrobial drugs. E. faecium 
were more resistant to most of the antibiotics than E. faecalis, particularly, gentamicin and erythromycin. This is 
similar to those reported by Mengeloğlu and colleagues (Mengeloğlu et al., 2011). However, resistance to 
erythromycin and gentamycin varies substantially in other studies depending on the setting. Frequencies of 100% and 
93.6% erythromycin resistance had been documented for E. faecalis and E. faecium respectively in a trial conducted in 
Spain (Aarestrup et al., 2002). In another instance, Peters and others observed that 74% of their E. faecalis strains and 
all their E. faecium strains were moderately or completely resistant to erythromycin (Peters et al., 2003). They also 
noted that the isolates showed low gentamicin resistance with 1% among E. faecalis isolates and 5% among E. faecium 
(Peters et al., 2003). The high resistance of our isolates to gentamicin is consistent with findings of some researchers 
who examined the carriage rate of vancomycin resistant enterococci among patients on prolonged hospitalization in 
Lagos University Teaching Hospital in Lagos, Nigeria (Ekuma et al., 2016). It has however been suggested that 
gentamicin resistance in enterococci is caused by the difficulty of penetration of this agent through the cell membrane 
and the secreting of the enzymes modifying gentamicin as a result of genes acquired by plasmids and transposons 
(Shepard and Gilmore, 2002).  
In this study, the sensitivity pattern observed for ofloxacin (a quinolone) was close to that reported by 
Mengeloglu et al. (2011). The workers observed that all E. faecium isolates investigated were resistant to ciprofloxacin, 
but the resistance rate in E. faecalis group was 65%. Both ofloxacin and ciprofloxacin belong to fluoroquinolone class 
of antimicrobial agents. Fluoroquinolones have been the preferred antibiotics for treatment of Enterococcus and 
resistance to the agent could have arisen principally from its misuse since antibiotics are readily available over–the–
counter in Nigeria. Resistance to several antibiotics has also been reported in other Nigerian studies (Olawale et al., 
2011, Ayeni et al., 2016).  
Glycopeptides (teicoplanin and vancomycin) are drugs that are rarely sold across the counter. Surprisingly, 
resistance to vancomycin was exhibited by some of our isolates. The resistance was however, higher in E. faecium 
(16.7%) than E. faecalis (10.4%). This was in contrast to the reported rate by Aarestrup et al. (2002) where 100% 
susceptibility to vancomycin in all E. faecalis isolates was recorded. Nevertheless, there was an agreement between our 
findings and that of Metiner et al. (2013) who observed that 26.6% of the E. faecalis strains isolated from pig faecal 
samples in Istanbul, Turkey were resistant to vancomycin while 6.4% of E. faecium were resistant to the antibiotic. 
Similar report from Northwest Ethiopia (Abebe et al., 2014) showed that prior antibiotic treatment was associated with 
vancomycin resistant enterococci colonization among clients with and without HIV. Although, we are not able to 
provide information on the use of antibiotics of the participants but expression of resistance is usually favoured by 
antibiotic misuse which conceivably can cause the emergence of vancomycin resistant isolates. As proposed by 
Teymournejad and others, expression of resistance genes and selection of strains already expressing these genes may 
alter the competing microbial flora in the GI tract, thereby increasing vancomycin resistant enterococcal concentration 
in the stools (Teymournejad et al., 2015). Based on this point, it is apparent that over-use or inappropriate use of this 
antibiotic may seriously compromise the treatment options for these organisms.   
 
Conclusion  
 
Our data indicate that while gender was not a determinant in Enterococcus carriage, high prevalence of 
resistant E. faecium and E. faecalis was identified among the individuals investigated. Resistance to gentamicin, 
erythromycin, ceftriaxone, ceftizoxime and cefuroxime were the most commonly detected among the two species. This 
infers that these antibiotics may not be suitable candidates for the treatment of enterococcal infections in our 
environment. We therefore stress the need for development of strategies to stop the sales of antibiotics across the 
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counter and create awareness among the populace by Government and Health Agencies on the consequences of 
unregulated antibiotic use. More detailed microbiological studies using genotypic methods are warranted. 
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